Roche

1Exits tracked$1.05bnDisclosed value$1.05bnMedian price0Acquihires

Photo: Shixart1985 / Wikimedia Commons, CC BY 2.0

Roche agrees to buy digital pathology company PathAI for up to $1.05 billion

Roche will pay $750 million upfront and up to $300 million in milestones for the Boston company, its partner since 2021, and plans to roll out PathAI's AISight lab software worldwide.

Price$1.05bnRaisedn/aLast stageSeries CBuyer typeCorporate

Latest in RocheMore stories here soon.

All Roche exitsOpen tracker →

7 MayRoche → PathAIBoston · Series C · raised n/a$1.05bn$1bn+